Ailux Appoints Lloyd S. Miller, M.D., Ph.D., as Chief Medical Officer
Dr. Miller will lead the advancement of the company’s AI-native biologics toward first-in-human trials, with initial clinical entry targeted for 2027 He will also establish a U.S. clinical and research site to complement the company’s research capabilities in Shanghai and the U.K. SHANGHAI and LONDON and SOMERVILLE, Mass., Oct. 13, 2026 /PRNewswire/ — Ailux, an […]







